LON:CREO Creo Medical Group (CREO) Share Price, News & Analysis GBX 10.18 +0.06 (+0.54%) As of 04:03 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and Trends About Creo Medical Group Stock (LON:CREO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Creo Medical Group alerts:Sign Up Key Stats Today's Range 10.08▼ 10.2550-Day Range 9.67▼ 12.7552-Week Range 9.50▼ 18.50Volume22,560 shsAverage Volume747,953 shsMarket Capitalization£45.72 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 40Consensus RatingN/A Company Overview Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue. Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions. CROMA currently delivers bipolar radiofrequency ("RF") energy for precise localised cutting and focused high frequency microwave ("MW") energy for controlled coagulation and ablation via a single accessory port. This technology, combined with the Group's range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions. The Directors believe the Company's technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option for procedures. For more information, please refer to the website www.creomedical.com Read More Receive CREO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CREO Stock News HeadlinesCreo Medical Group (LON:CREO) Stock Falls 1.2% - Should You Sell?November 14, 2026 | americanbankingnews.comCreo Records Lower H1 Loss Of £6 Mln; Full Year Revenue Growth Estimated At 50%-60%October 2, 2026 | rttnews.comPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027. | OilPrice (Ad)Earnings Flash (CREO.L) Creo Medical Group Reports H1 Revenue GBP3.2MSeptember 30, 2026 | marketscreener.comMCreo Medical Group PLC Reports Earnings Results for the Half Year Ended June 30, 2026September 30, 2026 | marketscreener.comMCreo Medical Raises FY26 Growth Forecast Following Strong First-Quarter Performance (CREO)June 29, 2026 | uk.finance.yahoo.comCreo Medical raises £5.5m and reaches deal to sell remaining stake in European ventureMay 26, 2026 | msn.comOne Creo Medical Group Insider Raised Stake By 15% In Previous YearMay 23, 2026 | finance.yahoo.comSee More Headlines CREO Stock Analysis - Frequently Asked Questions How have CREO shares performed this year? Creo Medical Group's stock was trading at GBX 10 on January 1st, 2026. Since then, CREO stock has increased by 0.7% and is now trading at GBX 10.08. How were Creo Medical Group's earnings last quarter? Creo Medical Group PLC (LON:CREO) announced its quarterly earnings data on Wednesday, September, 30th. The company reported GBX (2) EPS for the quarter. Creo Medical Group had a negative net margin of 268.57% and a negative trailing twelve-month return on equity of 38.29%. How do I buy shares of Creo Medical Group? Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Creo Medical Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), ITM Power (ITM), Legal & General Group (LGEN), Lloyds Banking Group (LLOY), M&G (MNG), Avacta Group (AVCT) and Barclays (BARC). Company Calendar Last Earnings9/30/2026Today11/18/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolLON:CREO CIKN/A Webcreomedical.com Phone+44-1291-606005FaxN/AEmployees279Year FoundedN/APrice Target and Rating Average Price Target for Creo Medical GroupGBX 40 High Price TargetGBX 40 Low Price TargetGBX 40 Potential Upside/Downside+290.2%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Trailing Twelve Months)GBX (5) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£25.04 million Net Margins-268.57% Pretax MarginN/A Return on Equity-38.29% Return on Assets-20.09% Debt Debt-to-Equity Ratio8.09 Current Ratio2.79 Quick Ratio2.19 Sales & Book Value Annual Sales£7 million Price / Sales6.58 Cash FlowGBX 4.22 per share Price / Cash Flow2.43 Book ValueGBX 13.11 per share Price / Book0.78Miscellaneous Outstanding Shares449,140,000Free FloatN/AMarket Cap£46.04 million OptionableNot Optionable Beta1.56 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (LON:CREO) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredAmerica's Biggest Bank… Down?About 4,800 Chase customers reported problems in just 15 minutes on Monday. Many couldn't log in or move money...Decentralized Masters | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.